ChemicalBook > Product Catalog >API >Urinary System Drugs >Diuretics Drugs >Hydrochlorothiazide

Hydrochlorothiazide

Hydrochlorothiazide Suppliers list
Company Name:Wuhan DKY Technology Co.,Ltd.  Gold
Tel:027-81302011 15347069687
Email:sales@whdky.com;2851686510@qq.com
Company Name:HuBei ShengBaoLai Biological Technology Co., Ltd  Gold
Tel:027-59105235 13007105135 15527244834
Email:sbl1120@163.com
Company Name:Shanghai Sphchem Co., Ltd.  Gold
Tel:+86 (21) 5649-1756+86 / 13512199871
Email:sales@sphchem.com
Company Name:Jiangxi Guifeng Technology Co., Ltd.  Gold
Tel:0791-86565026 15797847505
Email:gfkjjx@qq.com
Company Name:Shanghai Boyle Chemical Co., Ltd.  
Tel:Mr Qiu:021-50182298(Demestic market) Miss Xu:021-50180596(Abroad market)
Email:sales@boylechem.com
Hydrochlorothiazide Basic information
Outline Physical and Chemical Properties Pharmacological effects Pharmacokinetics Indications Dosage Adverse reactions Precautions Drug Interaction Formulation specifications Chemical Properties Uses Production method Category Toxicity grading Acute toxicity Flammability and hazard characteristics Storage property Extinguishing media
Product Name:Hydrochlorothiazide
Synonyms:2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide;2h-1,2,4-benzothiadiazine-7-sulfonamide,6-chloro-3,4-dihydro-,1,1-dioxide;3,4-Dihydro-6-chloro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide;6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide;6-Chloro-3,4-dihydro-7-sulphamoyl-1,2,4-ben-zoth-iadi-azine1,1-dioxcide;6-chloro-7-sulfamoyl-3,4-dihydro-2h-1,2,4-benzothiadiazine;6-Chloro-7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide;6-chloro-7-sulfamoyl-3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide
CAS:58-93-5
MF:C7H8ClN3O4S2
MW:297.74
EINECS:200-403-3
Product Categories:Losartan Potassium & Hydrochlorothiazide;Xanthones;Heterocyclic Compounds;Heterocycles;Inhibitors;Ion transporter and other ion channel;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;API;ESIDRIX;Other APIs;Pyrimidines ,Purines
Mol File:58-93-5.mol
Hydrochlorothiazide Structure
Hydrochlorothiazide Chemical Properties
mp 273 °C
storage temp. 2-8°C
Merck 14,4781
BRN 625101
Stability:Stable. Incompatible with strong oxidizing agents.
CAS DataBase Reference58-93-5(CAS DataBase Reference)
NIST Chemistry Reference6-Chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide(58-93-5)
EPA Substance Registry System2H-1,2,4-Benzothiadiazine- 7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide(58-93-5)
Safety Information
Hazard Codes Xi,T,F,Xn
Risk Statements 22-42/43-36/38-23/25-36/37/38-39/23/24/25-23/24/25-11
Safety Statements 22-24-36/37-45-33-16-7-36/37/39-27-26
RIDADR UN 1230 3/PG 2
RTECS DK9100000
Hazard Note Irritant
Hazardous Substances Data58-93-5(Hazardous Substances Data)
MSDS Information
ProviderLanguage
Hydrochlorothiazide English
ALFA English
Hydrochlorothiazide Usage And Synthesis
OutlineHydrochlorothiazide is a kind of thiazide diuretic drugs with moderate diuretic effect. It exert is diuretic effect through acting on the medullary ascending limb cortical segment, inhibiting the active re-absorption of Cl- and passive absorption of Na+ at this site. In addition, the product also has a hypotensive effect and anti-diuretic effect. It is suitable for treating a variety of edema, particularly for cardiogenic edema. It can also be used as antihypertensive agents, for treatment light, medium hypertension. It also has certain efficacy in treating diabetes insipidus, and idiopathic hypercalciuria. Commonly used thiazide diuretics include hydrochlorothiazide, chlorthalidone, indapamide and the like.
Physical and Chemical PropertiesIt is a white crystalline powder and is odorless with slightly bitter taste. It is insoluble in chloroform and water but soluble in acetone, slightly soluble in ethanol, soluble in sodium hydroxide solution but being susceptible to hydrolysis.
the structure formula of hydrochlorothiazide
Figure 1 is the structure formula of hydrochlorothiazide
Pharmacological effects1. Natriuretic effect: This product mainly inhibits the re-absorption of Na+, Cl- of distal tubule anterior part and proximal tubules (mild effect), and increasing urinary sodium, potassium, chlorine, phosphorus and magnesium ion excretion, and reducing urinary calcium excretion.
2. Antihypertensive effect: it has a moderate and precise antihypertensive effect and can reduce both the orthostatic, supine systolic and diastolic pressure and also enhance the hypotensive effect of other antihypertensive drugs.
3. Anti-diuretic effect: This product can reduce the amount of urine in nephrogenic diabetes insipidus, sometimes by 50% with the specific mechanism of action remaining unknown.
PharmacokineticsIt has rapid but incomplete oral absorption with heaving meal being able to increase the absorbed amount, which may be related with the prolonged residence time of drug in the small intestine. This product can partially bind to the plasma protein with the other part getting into the red blood cells. It takes effect at 2h after oral administration with the peak reaching in 4h. It duration time is 6 ~ 12h. It is mainly secreted in the prototype through the urinary excretion with the half-life (t1 / 2) being 15h and the t1/2 being extended in renal dysfunction.
The above information is edited by the chemicalbook of Dai Xiongfeng.
Indications1. Edema disease: including congestive heart failure, cirrhosis, nephrotic syndrome, acute and chronic nephritis edema, chronic renal failure early, adrenocorticotropic hormone and estrogen therapy caused retention of sodium and water.
2. High blood pressure: it can be used alone or in combination with other antihypertensive drugs. It is mainly used for the treatment of essential hypertension.
3. Central or nephrogenic diabetes insipidus.
4. Kidney stone disease: it is mainly used for the prevention of calcium stone formation.
DosageOral ordinary tablet: the efficacy onset of oral administration is in 2h with plasma concentration reaching peak at 4 hour and the effect lasting for 6 ~ 12h.
Adults: (1) for the treatment of edema disease, a 25 ~ 50mg, qd or bid, or qod; or take drug 3 ~ 5d weekly with a interval of 3 ~ 4d. (2) For the treatment of hypertension with the dose of 25 to 100 mg per day and divided into 1-2 times for administration. It needs to be used in combination with other antihypertensive drugs and should be subject to dose adjustment according to the actual antihypertensive effect. The dose is usually reduced to 25 to 50 mg per day within one week. (3) for the treatment of diabetes insipidus, take 25mg once tid, or 50 mg once, qd.
Children: treatment of edema disease, take 1 ~ 2mg / kg per day and divided 1-2 times for administration. Adjust the dose according to the actual efficacy.
Adverse reactionsMost adverse events are related to the dose and duration.
1. Water, electrolyte imbalance caused adverse reactions are the more common: hypokalemia is prone to occur and is related to the potassium excretion effect of thiazide diuretics. Long-term potassium deficiency can damage tubular with serious loss of potassium being able to cause vacuolar changes in the renal tubular epithelial and severe tachyarrhythmias and other ectopic rhythm. Thiazide class, especially hydrochlorothiazide can often significantly increases the excretion of chloride, causing low chlorine alkalosis or low chlorine, potassium alkalosis. In addition, hyponatremia is also not rare, causing central nervous system symptoms and aggravate kidney damage. Dehydration causes blood volume and renal blood flow reduction and can also cause reduced glomerular filtration rate. The common clinical manifestations of water, electrolyte imbalance include dry mouth, thirst, muscle cramps, nausea, vomiting and extreme fatigue, weakness and so on.
2. Hyperglycemia: It can make impaired glucose tolerance, elevated blood sugar, may be associated with inhibition of insulin release.
3. Hyperuricemia: it can interfere with renal tubular excretion of uric acid with a few being able to cause gout attacks. Usually it doesn’t cause joint pain, so hyperuricemia is easily overlooked.
4. Allergy: such as rash, urticaria; relatively rare.
5. Leukopenia or deficiency, and thrombocytopenic purpura, also rare.
6. Rare cholecystitis, pancreatitis, sexual dysfunction, light sensitivity, and color vision disorders.
Precautions1. Cross-allergy: it has cross-allergic reactions with the sulfa drugs, furosemide, bumetanide, and carbonic anhydrase inhibitors.
2. take it with caution in the following situations: ① anuria or severe renal dysfunction, due to the effect of the drugs is poor, large doses can cause drug accumulation, increase the toxicity; ② diabetes; ③ hyperuricemia or person with a history of gout; ④ for patients of severe liver dysfunction, water and electrolyte imbalance can induce hepatic encephalopathy; ⑤ hypercalcemia; ⑥ hyponatremia; ⑦ erythematosus, it can aggravate the condition or induced activity; ⑧ pancreatitis; ⑨ sympathectomy person (antihypertensive effect strengthened); ⑩ jaundice infant.
3. It can penetrate through the blood - the placental barrier. Pregnant women should take with caution. Lactating women is not recommended to use it.
4. For elderly patients, applying this class of drugs can easily cause hypotension, electrolyte imbalance and renal dysfunction.
5. They should start from the minimum effective dose in order to reduce the side effects as well as reduce the reflectivity of renin and aldosterone secretion.
6. For patients with a tendency with hypokalemia; we should supplement appropriate amount of potassium according to the actual situation or used in combination with potassium diuretics drug.
7. follow-up examination: ① serum electrolytes; ② glucose; ③ blood uric acid; ④ serum creatinine; ⑤ blood urea nitrogen; ⑥ blood pressure.
8. Interfere with the diagnosis: it can cause impaired glucose tolerance, elevated level of blood sugar, urine sugar, serum bilirubin, serum calcium, blood uric acid, blood cholesterol, triglycerides, low density lipoprotein concentration, and decreased level on serum magnesium, potassium, sodium and calcium.
9. Upon drug overdose, apply gastric lavage as soon as possible, give support, apply symptomatic treatment and have close monitoring on follow-up blood pressure, electrolytes and renal function.
Drug Interaction1. Adrenocorticotropic hormone, corticotropin, estrogens, amphotericin B (intravenous administration), can reduce the diuretic effect of this product and increase the chance of electrolyte imbalance, particularly hypokalemia.
2. Non-steroidal anti-inflammatory analgesic drugs, especially indomethacin, can reduce the diuretic effect of this product which is related with the former’s inhibition of prostaglandin synthesis.
3. Upon combination with the sympathomimetic amine drugs, its diuretic effect weakened.
4. Cholestyramine (cholestyramine) can reduce the gastrointestinal absorption of this product. Therefore, it should be taken orally at 1 h before or 4 h after taking the former drug.
5. In combination with dopamine, the diuretic effect strengthened.
6. In combination with antihypertensive drugs, both diuretic and antihypertensive effect were enhanced.
7. In combination with anti-gout drug, the dosage of the later one should be adjusted.
8. It can weaken the anticoagulant, mainly due to the decreased elevated levels of blood plasma volume after diuretic, elevated levels of blood clotting factors, together with the diuretic effect improving blood supplement in the liver, and increased synthesis of clotting factors.
9. It can reduce the role of hypoglycemic agents.
10. Upon being used combination with digitalis drugs or amiodarone, you should beware of adverse reactions caused by hypokalemia.
11. Upon being combination with lithium preparations, the product can reduce the renal clearance of lithium and increase renal toxicity of lithium.
12. The effect of methenamine is affected by this product with its conversion to formaldehyde being inhibited, decreasing the efficacy.
13. Enhance the non-depolarizing muscle relaxant effect which is related to a decline in serum potassium.
14. Upon being used in combination with sodium bicarbonate, the chances of low chlorine alkalosis increases.
Formulation specificationsHydrochlorothiazide tablets of 10, 25, 50mg.
Chemical PropertiesIt is a kind of white crystalline powder with the melting point being 273-275 ℃. It is soluble in acetone, slightly soluble in alcohol, insoluble in water, chloroform, ether, and soluble in sodium hydroxide solution but being susceptible to hydrolysis. It has a slightly bitter taste.
UsesThe product is a typical representative in the thiazide diuretic drug with its pharmaceutical sales in United States ranking first in 1985. Owing to its easy administration, moderate action as well as being suitable for all kinds of edema, it is most often clinically applied. Owing to adverse reactions like potassium secretion, we should pay attention to supplement potassium salt during the application. Intravenous injection-mice-LD50: 590mg / kg, oral LD50: greater than 8000mg / kg.
Diuretics
It mainly inhibits the re-absorption on Na+ and Cl- by the proximal end of the distal convoluted tubule so that renal excretion of sodium chloride is increased to produce a diuretic effect. It is a kind of diuretic drugs of moderate effect. This product has antihypertensive effect with the effect being enhanced when being use in combination with Lee medicine paste, antihypertensive shen paste or apocynum venetum and other traditional Chinese medicine. This product also has anti-diuretic effect and can be used for the treatment of diabetes insipidus
Production methodIt is produced by: m-Chlorosulfonated goes through chlorosulfonation to give 5-chloro-2,4-chloro-anilide, and further reacted with ammonia to form 5-chloro-2,4-sulfamoyl aniline which finally reacts with formaldehyde to obtain the final product.
Chemical PropertiesWhite Solid
Categorytoxic substances
UsageA carbonic anhydrase inhibitor. Diuretic.
UsageLabelled Hydrochlorothiazide (H714560). Hydrochlorothiazide is a carbonic anhydrase inhibitor as a diuretic.
Toxicity gradingpoisoning
Acute toxicityoral- rat LD50: 2750 mg / kg; Oral - Mouse LD50: 1175 mg / kg
Flammability and hazard characteristicscombustible; fire cause decomposition to release toxic gases such as hydrogen chloride, sulfur oxide, nitrogen oxide gases
Storage propertywarehouse: cold ventilation, drying
Extinguishing mediaWater, carbon dioxide, dry, sandy soil
General DescriptionCrystals or white powder.
Air & Water ReactionsInsoluble in water.
Reactivity ProfileStrong reducing agents will produce toxic gases ammonia and hydrogen sulfide.
Fire HazardFlash point data for Hydrochlorothiazide are not available but Hydrochlorothiazide is probably combustible.
Hydrochlorothiazide Preparation Products And Raw materials
Raw materials3-Chloroaniline-->4,4'-Diaminobenzanilide
Tag:Hydrochlorothiazide(58-93-5) Related Product Information
Methalthiazide paraflutizide Sumetizide bemetizide POLYTHIAZIDE (200 MG) Flurese Methyclothiazide ethiazide TRICHLORMETHIAZIDE teclothiazide Difluorochloromethane Hydrochlorothiazide Silicon dioxide Thiourea dioxide Titanium oxide CARBON DIOXIDE sulfur dioxide Chlorine dioxide